nodes	percent_of_prediction	percent_of_DWPC	metapath
Edetic Acid—ADA—Pentostatin—hematologic cancer	0.38	0.539	CbGbCtD
Edetic Acid—ADA—Nelarabine—hematologic cancer	0.218	0.31	CbGbCtD
Edetic Acid—CYP1A2—Anagrelide—hematologic cancer	0.0176	0.025	CbGbCtD
Edetic Acid—CYP19A1—Betamethasone—hematologic cancer	0.016	0.0228	CbGbCtD
Edetic Acid—CYP19A1—ovarian follicle—hematologic cancer	0.0132	0.311	CbGeAlD
Edetic Acid—CYP19A1—Dexamethasone—hematologic cancer	0.00932	0.0132	CbGbCtD
Edetic Acid—CYP1A2—Carmustine—hematologic cancer	0.00925	0.0131	CbGbCtD
Edetic Acid—CYP1A2—Methoxsalen—hematologic cancer	0.00786	0.0112	CbGbCtD
Edetic Acid—CYP1A2—Bortezomib—hematologic cancer	0.00748	0.0106	CbGbCtD
Edetic Acid—CYP1A2—Daunorubicin—hematologic cancer	0.00716	0.0102	CbGbCtD
Edetic Acid—CYP1A2—Alitretinoin—hematologic cancer	0.00701	0.00995	CbGbCtD
Edetic Acid—CYP1A2—Thalidomide—hematologic cancer	0.00652	0.00925	CbGbCtD
Edetic Acid—CYP1A2—Dacarbazine—hematologic cancer	0.0056	0.00796	CbGbCtD
Edetic Acid—CYP1A2—Imatinib—hematologic cancer	0.00548	0.00778	CbGbCtD
Edetic Acid—CYP1A2—Dasatinib—hematologic cancer	0.0044	0.00625	CbGbCtD
Edetic Acid—PON3—bone marrow—hematologic cancer	0.00365	0.0859	CbGeAlD
Edetic Acid—PON3—lung—hematologic cancer	0.00331	0.0778	CbGeAlD
Edetic Acid—PON3—testis—hematologic cancer	0.00312	0.0734	CbGeAlD
Edetic Acid—ADA—hematopoietic system—hematologic cancer	0.00299	0.0704	CbGeAlD
Edetic Acid—CYP1A2—Etoposide—hematologic cancer	0.00274	0.00389	CbGbCtD
Edetic Acid—ADA—blood—hematologic cancer	0.00198	0.0466	CbGeAlD
Edetic Acid—ADA—bone marrow—hematologic cancer	0.00192	0.0451	CbGeAlD
Edetic Acid—ADA—lung—hematologic cancer	0.00174	0.0409	CbGeAlD
Edetic Acid—ADA—testis—hematologic cancer	0.00164	0.0386	CbGeAlD
Edetic Acid—CYP19A1—hematopoietic system—hematologic cancer	0.00159	0.0375	CbGeAlD
Edetic Acid—CYP19A1—gonad—hematologic cancer	0.00121	0.0285	CbGeAlD
Edetic Acid—ADA—lymph node—hematologic cancer	0.00119	0.028	CbGeAlD
Edetic Acid—CYP1A2—hematopoietic system—hematologic cancer	0.00107	0.0251	CbGeAlD
Edetic Acid—CYP19A1—blood—hematologic cancer	0.00106	0.0248	CbGeAlD
Edetic Acid—CYP19A1—testis—hematologic cancer	0.000873	0.0205	CbGeAlD
Edetic Acid—CYP1A2—blood—hematologic cancer	0.000707	0.0166	CbGeAlD
Edetic Acid—CYP19A1—lymph node—hematologic cancer	0.000633	0.0149	CbGeAlD
Edetic Acid—CYP1A2—lung—hematologic cancer	0.00062	0.0146	CbGeAlD
Edetic Acid—Hypotension—Etoposide—hematologic cancer	5.53e-05	0.00032	CcSEcCtD
Edetic Acid—Rash—Bleomycin—hematologic cancer	5.53e-05	0.00032	CcSEcCtD
Edetic Acid—Pain—Cisplatin—hematologic cancer	5.52e-05	0.00032	CcSEcCtD
Edetic Acid—Dermatitis—Bleomycin—hematologic cancer	5.52e-05	0.00032	CcSEcCtD
Edetic Acid—Asthenia—Carmustine—hematologic cancer	5.49e-05	0.000318	CcSEcCtD
Edetic Acid—Vomiting—Vinorelbine—hematologic cancer	5.48e-05	0.000318	CcSEcCtD
Edetic Acid—Body temperature increased—Gemcitabine—hematologic cancer	5.48e-05	0.000317	CcSEcCtD
Edetic Acid—Diarrhoea—Thalidomide—hematologic cancer	5.45e-05	0.000316	CcSEcCtD
Edetic Acid—Asthenia—Alitretinoin—hematologic cancer	5.44e-05	0.000315	CcSEcCtD
Edetic Acid—Rash—Vinorelbine—hematologic cancer	5.44e-05	0.000315	CcSEcCtD
Edetic Acid—Dermatitis—Vinorelbine—hematologic cancer	5.43e-05	0.000315	CcSEcCtD
Edetic Acid—Headache—Vinorelbine—hematologic cancer	5.4e-05	0.000313	CcSEcCtD
Edetic Acid—Malaise—Dexamethasone—hematologic cancer	5.38e-05	0.000312	CcSEcCtD
Edetic Acid—Malaise—Betamethasone—hematologic cancer	5.38e-05	0.000312	CcSEcCtD
Edetic Acid—Asthenia—Ifosfamide—hematologic cancer	5.37e-05	0.000311	CcSEcCtD
Edetic Acid—Feeling abnormal—Cisplatin—hematologic cancer	5.32e-05	0.000308	CcSEcCtD
Edetic Acid—Paraesthesia—Etoposide—hematologic cancer	5.31e-05	0.000308	CcSEcCtD
Edetic Acid—Haematuria—Methotrexate—hematologic cancer	5.3e-05	0.000307	CcSEcCtD
Edetic Acid—Nausea—Bortezomib—hematologic cancer	5.25e-05	0.000304	CcSEcCtD
Edetic Acid—Asthenia—Vincristine—hematologic cancer	5.24e-05	0.000304	CcSEcCtD
Edetic Acid—Paraesthesia—Prednisolone—hematologic cancer	5.24e-05	0.000304	CcSEcCtD
Edetic Acid—Vomiting—Thiotepa—hematologic cancer	5.24e-05	0.000303	CcSEcCtD
Edetic Acid—Diarrhoea—Carmustine—hematologic cancer	5.24e-05	0.000303	CcSEcCtD
Edetic Acid—Nausea—Bleomycin—hematologic cancer	5.21e-05	0.000302	CcSEcCtD
Edetic Acid—Rash—Thiotepa—hematologic cancer	5.19e-05	0.000301	CcSEcCtD
Edetic Acid—Dermatitis—Thiotepa—hematologic cancer	5.19e-05	0.000301	CcSEcCtD
Edetic Acid—Diarrhoea—Alitretinoin—hematologic cancer	5.19e-05	0.0003	CcSEcCtD
Edetic Acid—Headache—Thiotepa—hematologic cancer	5.16e-05	0.000299	CcSEcCtD
Edetic Acid—Decreased appetite—Etoposide—hematologic cancer	5.14e-05	0.000298	CcSEcCtD
Edetic Acid—Diarrhoea—Ifosfamide—hematologic cancer	5.13e-05	0.000297	CcSEcCtD
Edetic Acid—Pancytopenia—Doxorubicin—hematologic cancer	5.12e-05	0.000297	CcSEcCtD
Edetic Acid—Nausea—Vinorelbine—hematologic cancer	5.12e-05	0.000297	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Etoposide—hematologic cancer	5.11e-05	0.000296	CcSEcCtD
Edetic Acid—Body temperature increased—Cisplatin—hematologic cancer	5.11e-05	0.000296	CcSEcCtD
Edetic Acid—Asthenia—Irinotecan—hematologic cancer	5.1e-05	0.000296	CcSEcCtD
Edetic Acid—Asthenia—Mitoxantrone—hematologic cancer	5.1e-05	0.000296	CcSEcCtD
Edetic Acid—Fatigue—Etoposide—hematologic cancer	5.1e-05	0.000296	CcSEcCtD
Edetic Acid—Myalgia—Dexamethasone—hematologic cancer	5.08e-05	0.000294	CcSEcCtD
Edetic Acid—Myalgia—Betamethasone—hematologic cancer	5.08e-05	0.000294	CcSEcCtD
Edetic Acid—Vomiting—Thalidomide—hematologic cancer	5.07e-05	0.000293	CcSEcCtD
Edetic Acid—Pain—Etoposide—hematologic cancer	5.06e-05	0.000293	CcSEcCtD
Edetic Acid—Rash—Thalidomide—hematologic cancer	5.02e-05	0.000291	CcSEcCtD
Edetic Acid—Discomfort—Dexamethasone—hematologic cancer	5.02e-05	0.000291	CcSEcCtD
Edetic Acid—Discomfort—Betamethasone—hematologic cancer	5.02e-05	0.000291	CcSEcCtD
Edetic Acid—Dermatitis—Thalidomide—hematologic cancer	5.02e-05	0.000291	CcSEcCtD
Edetic Acid—Diarrhoea—Vincristine—hematologic cancer	5e-05	0.00029	CcSEcCtD
Edetic Acid—Headache—Thalidomide—hematologic cancer	4.99e-05	0.000289	CcSEcCtD
Edetic Acid—Pain—Prednisolone—hematologic cancer	4.99e-05	0.000289	CcSEcCtD
Edetic Acid—Asthenia—Gemcitabine—hematologic cancer	4.97e-05	0.000288	CcSEcCtD
Edetic Acid—Haematuria—Epirubicin—hematologic cancer	4.96e-05	0.000287	CcSEcCtD
Edetic Acid—Nausea—Thiotepa—hematologic cancer	4.89e-05	0.000283	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	4.89e-05	0.000283	CcSEcCtD
Edetic Acid—Feeling abnormal—Etoposide—hematologic cancer	4.88e-05	0.000282	CcSEcCtD
Edetic Acid—Diarrhoea—Irinotecan—hematologic cancer	4.87e-05	0.000282	CcSEcCtD
Edetic Acid—Diarrhoea—Mitoxantrone—hematologic cancer	4.87e-05	0.000282	CcSEcCtD
Edetic Acid—Vomiting—Carmustine—hematologic cancer	4.86e-05	0.000282	CcSEcCtD
Edetic Acid—Rash—Carmustine—hematologic cancer	4.82e-05	0.000279	CcSEcCtD
Edetic Acid—Ill-defined disorder—Prednisone—hematologic cancer	4.82e-05	0.000279	CcSEcCtD
Edetic Acid—Dermatitis—Carmustine—hematologic cancer	4.82e-05	0.000279	CcSEcCtD
Edetic Acid—Vomiting—Alitretinoin—hematologic cancer	4.82e-05	0.000279	CcSEcCtD
Edetic Acid—Paraesthesia—Triamcinolone—hematologic cancer	4.82e-05	0.000279	CcSEcCtD
Edetic Acid—Feeling abnormal—Prednisolone—hematologic cancer	4.81e-05	0.000279	CcSEcCtD
Edetic Acid—Anaemia—Prednisone—hematologic cancer	4.8e-05	0.000278	CcSEcCtD
Edetic Acid—Headache—Carmustine—hematologic cancer	4.79e-05	0.000278	CcSEcCtD
Edetic Acid—Rash—Alitretinoin—hematologic cancer	4.78e-05	0.000277	CcSEcCtD
Edetic Acid—Dermatitis—Alitretinoin—hematologic cancer	4.77e-05	0.000277	CcSEcCtD
Edetic Acid—Vomiting—Ifosfamide—hematologic cancer	4.76e-05	0.000276	CcSEcCtD
Edetic Acid—Headache—Alitretinoin—hematologic cancer	4.75e-05	0.000275	CcSEcCtD
Edetic Acid—Diarrhoea—Gemcitabine—hematologic cancer	4.74e-05	0.000275	CcSEcCtD
Edetic Acid—Nausea—Thalidomide—hematologic cancer	4.73e-05	0.000274	CcSEcCtD
Edetic Acid—Rash—Ifosfamide—hematologic cancer	4.72e-05	0.000274	CcSEcCtD
Edetic Acid—Dermatitis—Ifosfamide—hematologic cancer	4.72e-05	0.000273	CcSEcCtD
Edetic Acid—Malaise—Prednisone—hematologic cancer	4.69e-05	0.000271	CcSEcCtD
Edetic Acid—Body temperature increased—Etoposide—hematologic cancer	4.68e-05	0.000271	CcSEcCtD
Edetic Acid—Hypoaesthesia—Epirubicin—hematologic cancer	4.64e-05	0.000269	CcSEcCtD
Edetic Acid—Vomiting—Vincristine—hematologic cancer	4.64e-05	0.000269	CcSEcCtD
Edetic Acid—Anorexia—Dexamethasone—hematologic cancer	4.64e-05	0.000269	CcSEcCtD
Edetic Acid—Anorexia—Betamethasone—hematologic cancer	4.64e-05	0.000269	CcSEcCtD
Edetic Acid—Asthenia—Cisplatin—hematologic cancer	4.63e-05	0.000268	CcSEcCtD
Edetic Acid—Fatigue—Triamcinolone—hematologic cancer	4.63e-05	0.000268	CcSEcCtD
Edetic Acid—Rash—Vincristine—hematologic cancer	4.61e-05	0.000267	CcSEcCtD
Edetic Acid—Dermatitis—Vincristine—hematologic cancer	4.6e-05	0.000267	CcSEcCtD
Edetic Acid—Pain—Triamcinolone—hematologic cancer	4.59e-05	0.000266	CcSEcCtD
Edetic Acid—Haematuria—Doxorubicin—hematologic cancer	4.59e-05	0.000266	CcSEcCtD
Edetic Acid—Headache—Vincristine—hematologic cancer	4.58e-05	0.000265	CcSEcCtD
Edetic Acid—Hypotension—Dexamethasone—hematologic cancer	4.55e-05	0.000264	CcSEcCtD
Edetic Acid—Hypotension—Betamethasone—hematologic cancer	4.55e-05	0.000264	CcSEcCtD
Edetic Acid—Nausea—Carmustine—hematologic cancer	4.54e-05	0.000263	CcSEcCtD
Edetic Acid—Vomiting—Irinotecan—hematologic cancer	4.52e-05	0.000262	CcSEcCtD
Edetic Acid—Vomiting—Mitoxantrone—hematologic cancer	4.52e-05	0.000262	CcSEcCtD
Edetic Acid—Nausea—Alitretinoin—hematologic cancer	4.5e-05	0.000261	CcSEcCtD
Edetic Acid—Rash—Mitoxantrone—hematologic cancer	4.49e-05	0.00026	CcSEcCtD
Edetic Acid—Rash—Irinotecan—hematologic cancer	4.49e-05	0.00026	CcSEcCtD
Edetic Acid—Dermatitis—Mitoxantrone—hematologic cancer	4.48e-05	0.00026	CcSEcCtD
Edetic Acid—Dermatitis—Irinotecan—hematologic cancer	4.48e-05	0.00026	CcSEcCtD
Edetic Acid—Chills—Methotrexate—hematologic cancer	4.48e-05	0.000259	CcSEcCtD
Edetic Acid—Headache—Irinotecan—hematologic cancer	4.46e-05	0.000258	CcSEcCtD
Edetic Acid—Headache—Mitoxantrone—hematologic cancer	4.46e-05	0.000258	CcSEcCtD
Edetic Acid—Nausea—Ifosfamide—hematologic cancer	4.45e-05	0.000258	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.44e-05	0.000257	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.44e-05	0.000257	CcSEcCtD
Edetic Acid—Arthralgia—Prednisone—hematologic cancer	4.42e-05	0.000256	CcSEcCtD
Edetic Acid—Myalgia—Prednisone—hematologic cancer	4.42e-05	0.000256	CcSEcCtD
Edetic Acid—Feeling abnormal—Triamcinolone—hematologic cancer	4.42e-05	0.000256	CcSEcCtD
Edetic Acid—Diarrhoea—Cisplatin—hematologic cancer	4.42e-05	0.000256	CcSEcCtD
Edetic Acid—Vomiting—Gemcitabine—hematologic cancer	4.41e-05	0.000255	CcSEcCtD
Edetic Acid—Paraesthesia—Betamethasone—hematologic cancer	4.37e-05	0.000253	CcSEcCtD
Edetic Acid—Paraesthesia—Dexamethasone—hematologic cancer	4.37e-05	0.000253	CcSEcCtD
Edetic Acid—Discomfort—Prednisone—hematologic cancer	4.37e-05	0.000253	CcSEcCtD
Edetic Acid—Rash—Gemcitabine—hematologic cancer	4.37e-05	0.000253	CcSEcCtD
Edetic Acid—Dermatitis—Gemcitabine—hematologic cancer	4.36e-05	0.000253	CcSEcCtD
Edetic Acid—Headache—Gemcitabine—hematologic cancer	4.34e-05	0.000251	CcSEcCtD
Edetic Acid—Nausea—Vincristine—hematologic cancer	4.34e-05	0.000251	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	4.32e-05	0.000536	CbGpPWpGaD
Edetic Acid—Hypoaesthesia—Doxorubicin—hematologic cancer	4.3e-05	0.000249	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	4.29e-05	0.000532	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—BAD—hematologic cancer	4.28e-05	0.00053	CbGpPWpGaD
Edetic Acid—Asthenia—Etoposide—hematologic cancer	4.25e-05	0.000246	CcSEcCtD
Edetic Acid—Body temperature increased—Triamcinolone—hematologic cancer	4.24e-05	0.000246	CcSEcCtD
Edetic Acid—Decreased appetite—Dexamethasone—hematologic cancer	4.23e-05	0.000245	CcSEcCtD
Edetic Acid—Decreased appetite—Betamethasone—hematologic cancer	4.23e-05	0.000245	CcSEcCtD
Edetic Acid—Nausea—Irinotecan—hematologic cancer	4.23e-05	0.000245	CcSEcCtD
Edetic Acid—Nausea—Mitoxantrone—hematologic cancer	4.23e-05	0.000245	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.2e-05	0.000244	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.2e-05	0.000244	CcSEcCtD
Edetic Acid—Fatigue—Betamethasone—hematologic cancer	4.2e-05	0.000243	CcSEcCtD
Edetic Acid—Fatigue—Dexamethasone—hematologic cancer	4.2e-05	0.000243	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—PHYH—hematologic cancer	4.19e-05	0.00052	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—FTCD—hematologic cancer	4.19e-05	0.00052	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GMPS—hematologic cancer	4.19e-05	0.00052	CbGpPWpGaD
Edetic Acid—Chills—Epirubicin—hematologic cancer	4.19e-05	0.000243	CcSEcCtD
Edetic Acid—ADA—Metabolism—IDH1—hematologic cancer	4.18e-05	0.000518	CbGpPWpGaD
Edetic Acid—Pain—Betamethasone—hematologic cancer	4.16e-05	0.000241	CcSEcCtD
Edetic Acid—Pain—Dexamethasone—hematologic cancer	4.16e-05	0.000241	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	4.15e-05	0.000514	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GSTO1—hematologic cancer	4.13e-05	0.000512	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—TXN—hematologic cancer	4.13e-05	0.000512	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—ABCC3—hematologic cancer	4.13e-05	0.000512	CbGpPWpGaD
Edetic Acid—Nausea—Gemcitabine—hematologic cancer	4.12e-05	0.000238	CcSEcCtD
Edetic Acid—Vomiting—Cisplatin—hematologic cancer	4.11e-05	0.000238	CcSEcCtD
Edetic Acid—Rash—Cisplatin—hematologic cancer	4.07e-05	0.000236	CcSEcCtD
Edetic Acid—Dermatitis—Cisplatin—hematologic cancer	4.07e-05	0.000236	CcSEcCtD
Edetic Acid—Diarrhoea—Etoposide—hematologic cancer	4.05e-05	0.000235	CcSEcCtD
Edetic Acid—Anorexia—Prednisone—hematologic cancer	4.04e-05	0.000234	CcSEcCtD
Edetic Acid—ADA—Metabolism—SPHK1—hematologic cancer	4.04e-05	0.000501	CbGpPWpGaD
Edetic Acid—Ill-defined disorder—Methotrexate—hematologic cancer	4.03e-05	0.000233	CcSEcCtD
Edetic Acid—Anaemia—Methotrexate—hematologic cancer	4.01e-05	0.000233	CcSEcCtD
Edetic Acid—Feeling abnormal—Dexamethasone—hematologic cancer	4.01e-05	0.000232	CcSEcCtD
Edetic Acid—Feeling abnormal—Betamethasone—hematologic cancer	4.01e-05	0.000232	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	3.95e-05	0.00049	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CREB1—hematologic cancer	3.94e-05	0.000489	CbGpPWpGaD
Edetic Acid—Malaise—Methotrexate—hematologic cancer	3.92e-05	0.000227	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	3.91e-05	0.000485	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—BRAF—hematologic cancer	3.89e-05	0.000483	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—UGT1A1—hematologic cancer	3.88e-05	0.000481	CbGpPWpGaD
Edetic Acid—Chills—Doxorubicin—hematologic cancer	3.88e-05	0.000225	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.86e-05	0.000224	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CASP8—hematologic cancer	3.86e-05	0.000478	CbGpPWpGaD
Edetic Acid—Asthenia—Triamcinolone—hematologic cancer	3.85e-05	0.000223	CcSEcCtD
Edetic Acid—Body temperature increased—Dexamethasone—hematologic cancer	3.85e-05	0.000223	CcSEcCtD
Edetic Acid—Body temperature increased—Betamethasone—hematologic cancer	3.85e-05	0.000223	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	3.85e-05	0.000477	CbGpPWpGaD
Edetic Acid—Nausea—Cisplatin—hematologic cancer	3.84e-05	0.000222	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—SMPD3—hematologic cancer	3.83e-05	0.000475	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—RB1—hematologic cancer	3.83e-05	0.000474	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	3.83e-05	0.000474	CbGpPWpGaD
Edetic Acid—Paraesthesia—Prednisone—hematologic cancer	3.81e-05	0.000221	CcSEcCtD
Edetic Acid—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	3.8e-05	0.000471	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—SLC22A1—hematologic cancer	3.78e-05	0.000468	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CRABP1—hematologic cancer	3.78e-05	0.000468	CbGpPWpGaD
Edetic Acid—Ill-defined disorder—Epirubicin—hematologic cancer	3.77e-05	0.000218	CcSEcCtD
Edetic Acid—Vomiting—Etoposide—hematologic cancer	3.76e-05	0.000218	CcSEcCtD
Edetic Acid—Anaemia—Epirubicin—hematologic cancer	3.76e-05	0.000218	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	3.75e-05	0.000464	CbGpPWpGaD
Edetic Acid—Rash—Etoposide—hematologic cancer	3.73e-05	0.000216	CcSEcCtD
Edetic Acid—Dermatitis—Etoposide—hematologic cancer	3.73e-05	0.000216	CcSEcCtD
Edetic Acid—Headache—Etoposide—hematologic cancer	3.71e-05	0.000215	CcSEcCtD
Edetic Acid—Arthralgia—Methotrexate—hematologic cancer	3.7e-05	0.000214	CcSEcCtD
Edetic Acid—Myalgia—Methotrexate—hematologic cancer	3.7e-05	0.000214	CcSEcCtD
Edetic Acid—Decreased appetite—Prednisone—hematologic cancer	3.69e-05	0.000214	CcSEcCtD
Edetic Acid—ADA—Metabolism—ALOX5—hematologic cancer	3.68e-05	0.000456	CbGpPWpGaD
Edetic Acid—Rash—Prednisolone—hematologic cancer	3.68e-05	0.000213	CcSEcCtD
Edetic Acid—Dermatitis—Prednisolone—hematologic cancer	3.68e-05	0.000213	CcSEcCtD
Edetic Acid—Malaise—Epirubicin—hematologic cancer	3.66e-05	0.000212	CcSEcCtD
Edetic Acid—Fatigue—Prednisone—hematologic cancer	3.66e-05	0.000212	CcSEcCtD
Edetic Acid—Headache—Prednisolone—hematologic cancer	3.66e-05	0.000212	CcSEcCtD
Edetic Acid—Discomfort—Methotrexate—hematologic cancer	3.65e-05	0.000212	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	3.62e-05	0.000449	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	3.59e-05	0.000445	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	3.58e-05	0.000443	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	3.57e-05	0.000443	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—NUP98—hematologic cancer	3.56e-05	0.000442	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	3.56e-05	0.000441	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	3.54e-05	0.000438	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—TP53—hematologic cancer	3.53e-05	0.000438	CbGpPWpGaD
Edetic Acid—Nausea—Etoposide—hematologic cancer	3.51e-05	0.000204	CcSEcCtD
Edetic Acid—Feeling abnormal—Prednisone—hematologic cancer	3.49e-05	0.000202	CcSEcCtD
Edetic Acid—Asthenia—Dexamethasone—hematologic cancer	3.49e-05	0.000202	CcSEcCtD
Edetic Acid—Asthenia—Betamethasone—hematologic cancer	3.49e-05	0.000202	CcSEcCtD
Edetic Acid—Ill-defined disorder—Doxorubicin—hematologic cancer	3.49e-05	0.000202	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	3.48e-05	0.000432	CbGpPWpGaD
Edetic Acid—Anaemia—Doxorubicin—hematologic cancer	3.48e-05	0.000201	CcSEcCtD
Edetic Acid—Nausea—Prednisolone—hematologic cancer	3.47e-05	0.000201	CcSEcCtD
Edetic Acid—ADA—Metabolism—NCOA3—hematologic cancer	3.46e-05	0.000429	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—ADCY7—hematologic cancer	3.46e-05	0.000429	CbGpPWpGaD
Edetic Acid—Arthralgia—Epirubicin—hematologic cancer	3.46e-05	0.0002	CcSEcCtD
Edetic Acid—Myalgia—Epirubicin—hematologic cancer	3.46e-05	0.0002	CcSEcCtD
Edetic Acid—ADA—Metabolism—NUP214—hematologic cancer	3.44e-05	0.000426	CbGpPWpGaD
Edetic Acid—Discomfort—Epirubicin—hematologic cancer	3.42e-05	0.000198	CcSEcCtD
Edetic Acid—Vomiting—Triamcinolone—hematologic cancer	3.41e-05	0.000198	CcSEcCtD
Edetic Acid—Malaise—Doxorubicin—hematologic cancer	3.39e-05	0.000196	CcSEcCtD
Edetic Acid—Rash—Triamcinolone—hematologic cancer	3.38e-05	0.000196	CcSEcCtD
Edetic Acid—Dermatitis—Triamcinolone—hematologic cancer	3.38e-05	0.000196	CcSEcCtD
Edetic Acid—Anorexia—Methotrexate—hematologic cancer	3.38e-05	0.000196	CcSEcCtD
Edetic Acid—ADA—Metabolism—ABCG2—hematologic cancer	3.37e-05	0.000417	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—MTR—hematologic cancer	3.37e-05	0.000417	CbGpPWpGaD
Edetic Acid—Headache—Triamcinolone—hematologic cancer	3.36e-05	0.000195	CcSEcCtD
Edetic Acid—Body temperature increased—Prednisone—hematologic cancer	3.35e-05	0.000194	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—B3GAT1—hematologic cancer	3.35e-05	0.000416	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—DCK—hematologic cancer	3.35e-05	0.000416	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ASNS—hematologic cancer	3.35e-05	0.000416	CbGpPWpGaD
Edetic Acid—Diarrhoea—Dexamethasone—hematologic cancer	3.33e-05	0.000193	CcSEcCtD
Edetic Acid—Diarrhoea—Betamethasone—hematologic cancer	3.33e-05	0.000193	CcSEcCtD
Edetic Acid—Hypotension—Methotrexate—hematologic cancer	3.31e-05	0.000192	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	3.31e-05	0.000411	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—ENO2—hematologic cancer	3.3e-05	0.000409	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	3.28e-05	0.000406	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	3.26e-05	0.000405	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	3.26e-05	0.000404	CbGpPWpGaD
Edetic Acid—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	3.25e-05	0.000403	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—IL6—hematologic cancer	3.23e-05	0.000401	CbGpPWpGaD
Edetic Acid—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.23e-05	0.000187	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	3.21e-05	0.000398	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GSTT1—hematologic cancer	3.2e-05	0.000397	CbGpPWpGaD
Edetic Acid—Myalgia—Doxorubicin—hematologic cancer	3.2e-05	0.000185	CcSEcCtD
Edetic Acid—Arthralgia—Doxorubicin—hematologic cancer	3.2e-05	0.000185	CcSEcCtD
Edetic Acid—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	3.19e-05	0.000396	CbGpPWpGaD
Edetic Acid—Nausea—Triamcinolone—hematologic cancer	3.19e-05	0.000185	CcSEcCtD
Edetic Acid—Paraesthesia—Methotrexate—hematologic cancer	3.18e-05	0.000184	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—HDC—hematologic cancer	3.18e-05	0.000394	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	3.17e-05	0.000394	CbGpPWpGaD
Edetic Acid—Discomfort—Doxorubicin—hematologic cancer	3.16e-05	0.000183	CcSEcCtD
Edetic Acid—Anorexia—Epirubicin—hematologic cancer	3.16e-05	0.000183	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—MTR—hematologic cancer	3.14e-05	0.000389	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—SDC1—hematologic cancer	3.13e-05	0.000388	CbGpPWpGaD
Edetic Acid—Hypotension—Epirubicin—hematologic cancer	3.1e-05	0.00018	CcSEcCtD
Edetic Acid—Vomiting—Betamethasone—hematologic cancer	3.1e-05	0.000179	CcSEcCtD
Edetic Acid—Vomiting—Dexamethasone—hematologic cancer	3.1e-05	0.000179	CcSEcCtD
Edetic Acid—Decreased appetite—Methotrexate—hematologic cancer	3.08e-05	0.000178	CcSEcCtD
Edetic Acid—Rash—Betamethasone—hematologic cancer	3.07e-05	0.000178	CcSEcCtD
Edetic Acid—Rash—Dexamethasone—hematologic cancer	3.07e-05	0.000178	CcSEcCtD
Edetic Acid—Dermatitis—Betamethasone—hematologic cancer	3.07e-05	0.000178	CcSEcCtD
Edetic Acid—Dermatitis—Dexamethasone—hematologic cancer	3.07e-05	0.000178	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.06e-05	0.000177	CcSEcCtD
Edetic Acid—Fatigue—Methotrexate—hematologic cancer	3.06e-05	0.000177	CcSEcCtD
Edetic Acid—Headache—Betamethasone—hematologic cancer	3.05e-05	0.000177	CcSEcCtD
Edetic Acid—Headache—Dexamethasone—hematologic cancer	3.05e-05	0.000177	CcSEcCtD
Edetic Acid—Asthenia—Prednisone—hematologic cancer	3.04e-05	0.000176	CcSEcCtD
Edetic Acid—Pain—Methotrexate—hematologic cancer	3.03e-05	0.000176	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.02e-05	0.000175	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	2.98e-05	0.00037	CbGpPWpGaD
Edetic Acid—Paraesthesia—Epirubicin—hematologic cancer	2.98e-05	0.000173	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.96e-05	0.000367	CbGpPWpGaD
Edetic Acid—Anorexia—Doxorubicin—hematologic cancer	2.93e-05	0.000169	CcSEcCtD
Edetic Acid—Feeling abnormal—Methotrexate—hematologic cancer	2.92e-05	0.000169	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	2.92e-05	0.000362	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	2.92e-05	0.000361	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	2.92e-05	0.000361	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CDA—hematologic cancer	2.91e-05	0.00036	CbGpPWpGaD
Edetic Acid—Diarrhoea—Prednisone—hematologic cancer	2.9e-05	0.000168	CcSEcCtD
Edetic Acid—Nausea—Dexamethasone—hematologic cancer	2.89e-05	0.000168	CcSEcCtD
Edetic Acid—Nausea—Betamethasone—hematologic cancer	2.89e-05	0.000168	CcSEcCtD
Edetic Acid—Decreased appetite—Epirubicin—hematologic cancer	2.88e-05	0.000167	CcSEcCtD
Edetic Acid—Hypotension—Doxorubicin—hematologic cancer	2.87e-05	0.000166	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	2.86e-05	0.000355	CbGpPWpGaD
Edetic Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.86e-05	0.000166	CcSEcCtD
Edetic Acid—Fatigue—Epirubicin—hematologic cancer	2.86e-05	0.000166	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	2.85e-05	0.000354	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	2.84e-05	0.000352	CbGpPWpGaD
Edetic Acid—Pain—Epirubicin—hematologic cancer	2.84e-05	0.000164	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—JUN—hematologic cancer	2.84e-05	0.000352	CbGpPWpGaD
Edetic Acid—Body temperature increased—Methotrexate—hematologic cancer	2.8e-05	0.000162	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—PC—hematologic cancer	2.8e-05	0.000347	CbGpPWpGaD
Edetic Acid—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.8e-05	0.000162	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	2.78e-05	0.000344	CbGpPWpGaD
Edetic Acid—Paraesthesia—Doxorubicin—hematologic cancer	2.76e-05	0.00016	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	2.74e-05	0.00034	CbGpPWpGaD
Edetic Acid—Feeling abnormal—Epirubicin—hematologic cancer	2.73e-05	0.000158	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—GBA—hematologic cancer	2.7e-05	0.000335	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—SLC35B2—hematologic cancer	2.7e-05	0.000335	CbGpPWpGaD
Edetic Acid—Vomiting—Prednisone—hematologic cancer	2.7e-05	0.000156	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	2.69e-05	0.000334	CbGpPWpGaD
Edetic Acid—Rash—Prednisone—hematologic cancer	2.67e-05	0.000155	CcSEcCtD
Edetic Acid—Dermatitis—Prednisone—hematologic cancer	2.67e-05	0.000155	CcSEcCtD
Edetic Acid—Decreased appetite—Doxorubicin—hematologic cancer	2.67e-05	0.000155	CcSEcCtD
Edetic Acid—ADA—Metabolism—NQO1—hematologic cancer	2.66e-05	0.00033	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CD44—hematologic cancer	2.66e-05	0.00033	CbGpPWpGaD
Edetic Acid—Headache—Prednisone—hematologic cancer	2.66e-05	0.000154	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.65e-05	0.000153	CcSEcCtD
Edetic Acid—Fatigue—Doxorubicin—hematologic cancer	2.65e-05	0.000153	CcSEcCtD
Edetic Acid—Pain—Doxorubicin—hematologic cancer	2.62e-05	0.000152	CcSEcCtD
Edetic Acid—Body temperature increased—Epirubicin—hematologic cancer	2.62e-05	0.000152	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—EP300—hematologic cancer	2.62e-05	0.000324	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	2.56e-05	0.000317	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	2.56e-05	0.000317	CbGpPWpGaD
Edetic Acid—Asthenia—Methotrexate—hematologic cancer	2.54e-05	0.000147	CcSEcCtD
Edetic Acid—Feeling abnormal—Doxorubicin—hematologic cancer	2.53e-05	0.000147	CcSEcCtD
Edetic Acid—Nausea—Prednisone—hematologic cancer	2.52e-05	0.000146	CcSEcCtD
Edetic Acid—ADA—Metabolism—CYCS—hematologic cancer	2.52e-05	0.000312	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—HSP90AA1—hematologic cancer	2.5e-05	0.00031	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	2.49e-05	0.000309	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	2.49e-05	0.000309	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	2.48e-05	0.000307	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—MTAP—hematologic cancer	2.47e-05	0.000306	CbGpPWpGaD
Edetic Acid—Body temperature increased—Doxorubicin—hematologic cancer	2.43e-05	0.000141	CcSEcCtD
Edetic Acid—Diarrhoea—Methotrexate—hematologic cancer	2.42e-05	0.00014	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	2.42e-05	0.000301	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	2.4e-05	0.000297	CbGpPWpGaD
Edetic Acid—Asthenia—Epirubicin—hematologic cancer	2.38e-05	0.000138	CcSEcCtD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.29e-05	0.000284	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MYC—hematologic cancer	2.28e-05	0.000283	CbGpPWpGaD
Edetic Acid—Diarrhoea—Epirubicin—hematologic cancer	2.27e-05	0.000131	CcSEcCtD
Edetic Acid—Vomiting—Methotrexate—hematologic cancer	2.25e-05	0.000131	CcSEcCtD
Edetic Acid—Rash—Methotrexate—hematologic cancer	2.23e-05	0.000129	CcSEcCtD
Edetic Acid—Dermatitis—Methotrexate—hematologic cancer	2.23e-05	0.000129	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	2.23e-05	0.000277	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	2.23e-05	0.000276	CbGpPWpGaD
Edetic Acid—Headache—Methotrexate—hematologic cancer	2.22e-05	0.000129	CcSEcCtD
Edetic Acid—ADA—Metabolism—GSTP1—hematologic cancer	2.22e-05	0.000275	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—FHL2—hematologic cancer	2.2e-05	0.000273	CbGpPWpGaD
Edetic Acid—Asthenia—Doxorubicin—hematologic cancer	2.2e-05	0.000128	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—AGRN—hematologic cancer	2.16e-05	0.000268	CbGpPWpGaD
Edetic Acid—Vomiting—Epirubicin—hematologic cancer	2.11e-05	0.000122	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	2.11e-05	0.000261	CbGpPWpGaD
Edetic Acid—Nausea—Methotrexate—hematologic cancer	2.11e-05	0.000122	CcSEcCtD
Edetic Acid—ADA—Metabolism—ABCB1—hematologic cancer	2.1e-05	0.00026	CbGpPWpGaD
Edetic Acid—Diarrhoea—Doxorubicin—hematologic cancer	2.1e-05	0.000122	CcSEcCtD
Edetic Acid—Rash—Epirubicin—hematologic cancer	2.09e-05	0.000121	CcSEcCtD
Edetic Acid—Dermatitis—Epirubicin—hematologic cancer	2.09e-05	0.000121	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	2.08e-05	0.000258	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	2.08e-05	0.000258	CbGpPWpGaD
Edetic Acid—Headache—Epirubicin—hematologic cancer	2.08e-05	0.00012	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	2.07e-05	0.000256	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	2.06e-05	0.000256	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—HMMR—hematologic cancer	2.05e-05	0.000254	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—IDH2—hematologic cancer	2.05e-05	0.000254	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	2.04e-05	0.000253	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—NCOR1—hematologic cancer	2.04e-05	0.000253	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—GSTM1—hematologic cancer	2.04e-05	0.000253	CbGpPWpGaD
Edetic Acid—Nausea—Epirubicin—hematologic cancer	1.97e-05	0.000114	CcSEcCtD
Edetic Acid—Vomiting—Doxorubicin—hematologic cancer	1.95e-05	0.000113	CcSEcCtD
Edetic Acid—Rash—Doxorubicin—hematologic cancer	1.93e-05	0.000112	CcSEcCtD
Edetic Acid—Dermatitis—Doxorubicin—hematologic cancer	1.93e-05	0.000112	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.93e-05	0.000239	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ARNTL—hematologic cancer	1.92e-05	0.000239	CbGpPWpGaD
Edetic Acid—Headache—Doxorubicin—hematologic cancer	1.92e-05	0.000111	CcSEcCtD
Edetic Acid—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	1.9e-05	0.000236	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	1.87e-05	0.000232	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CA9—hematologic cancer	1.87e-05	0.000232	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ACP5—hematologic cancer	1.87e-05	0.000232	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—TP53—hematologic cancer	1.87e-05	0.000232	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	1.87e-05	0.000232	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NCOR2—hematologic cancer	1.85e-05	0.000229	CbGpPWpGaD
Edetic Acid—Nausea—Doxorubicin—hematologic cancer	1.82e-05	0.000106	CcSEcCtD
Edetic Acid—ADA—Metabolism—MTHFR—hematologic cancer	1.8e-05	0.000223	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—IDH1—hematologic cancer	1.76e-05	0.000218	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	1.75e-05	0.000217	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ABCC3—hematologic cancer	1.74e-05	0.000216	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTO1—hematologic cancer	1.74e-05	0.000216	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—TXN—hematologic cancer	1.74e-05	0.000216	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—SPHK1—hematologic cancer	1.7e-05	0.000211	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—UGT1A1—hematologic cancer	1.64e-05	0.000203	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.63e-05	0.000203	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CRABP1—hematologic cancer	1.59e-05	0.000197	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—SLC22A1—hematologic cancer	1.59e-05	0.000197	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—FTCD—hematologic cancer	1.59e-05	0.000197	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PHYH—hematologic cancer	1.59e-05	0.000197	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GMPS—hematologic cancer	1.59e-05	0.000197	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	1.58e-05	0.000196	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.57e-05	0.000195	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ALOX5—hematologic cancer	1.55e-05	0.000192	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CG—hematologic cancer	1.51e-05	0.000188	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NUP98—hematologic cancer	1.5e-05	0.000186	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.49e-05	0.000185	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.48e-05	0.000183	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ADCY7—hematologic cancer	1.46e-05	0.000181	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NCOA3—hematologic cancer	1.46e-05	0.000181	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.45e-05	0.00018	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NUP214—hematologic cancer	1.45e-05	0.00018	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.45e-05	0.000179	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.43e-05	0.000178	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ABCG2—hematologic cancer	1.42e-05	0.000176	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—MTR—hematologic cancer	1.42e-05	0.000176	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CREBBP—hematologic cancer	1.4e-05	0.000174	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ENO2—hematologic cancer	1.39e-05	0.000173	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.35e-05	0.000168	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTT1—hematologic cancer	1.35e-05	0.000167	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CD—hematologic cancer	1.33e-05	0.000165	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.33e-05	0.000165	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—SDC1—hematologic cancer	1.32e-05	0.000164	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.32e-05	0.000163	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—ALB—hematologic cancer	1.31e-05	0.000163	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ASNS—hematologic cancer	1.27e-05	0.000157	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—DCK—hematologic cancer	1.27e-05	0.000157	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.27e-05	0.000157	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.26e-05	0.000156	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3R1—hematologic cancer	1.26e-05	0.000156	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.24e-05	0.000154	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.24e-05	0.000154	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—HDC—hematologic cancer	1.2e-05	0.000149	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.19e-05	0.000148	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CB—hematologic cancer	1.16e-05	0.000144	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NQO1—hematologic cancer	1.12e-05	0.000139	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CD44—hematologic cancer	1.12e-05	0.000139	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.12e-05	0.000139	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CDA—hematologic cancer	1.1e-05	0.000136	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.1e-05	0.000136	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CYCS—hematologic cancer	1.06e-05	0.000132	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PC—hematologic cancer	1.06e-05	0.000131	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—HSP90AA1—hematologic cancer	1.05e-05	0.000131	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GBA—hematologic cancer	1.02e-05	0.000127	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.02e-05	0.000127	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PTEN—hematologic cancer	1e-05	0.000124	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—EP300—hematologic cancer	9.56e-06	0.000119	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.49e-06	0.000118	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTP1—hematologic cancer	9.36e-06	0.000116	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—MTAP—hematologic cancer	9.34e-06	0.000116	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.05e-06	0.000112	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ABCB1—hematologic cancer	8.86e-06	0.00011	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—GSTM1—hematologic cancer	8.6e-06	0.000107	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—NCOR1—hematologic cancer	8.6e-06	0.000107	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—FHL2—hematologic cancer	8.33e-06	0.000103	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—AGRN—hematologic cancer	8.17e-06	0.000101	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—IDH2—hematologic cancer	7.74e-06	9.6e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—HMMR—hematologic cancer	7.74e-06	9.6e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—MTHFR—hematologic cancer	7.6e-06	9.42e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.3e-06	9.05e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ARNTL—hematologic cancer	7.28e-06	9.02e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ACP5—hematologic cancer	7.08e-06	8.78e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CA9—hematologic cancer	7.08e-06	8.78e-05	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CA—hematologic cancer	7.07e-06	8.77e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.99e-06	8.66e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.7e-06	8.3e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—IDH1—hematologic cancer	6.66e-06	8.25e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.58e-06	8.16e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.58e-06	8.16e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—TXN—hematologic cancer	6.58e-06	8.16e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.44e-06	7.99e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CG—hematologic cancer	6.38e-06	7.92e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.19e-06	7.67e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.02e-06	7.46e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.02e-06	7.46e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CREBBP—hematologic cancer	5.92e-06	7.34e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.87e-06	7.27e-05	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—AKT1—hematologic cancer	5.78e-06	7.16e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NUP98—hematologic cancer	5.68e-06	7.04e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CD—hematologic cancer	5.61e-06	6.96e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ALB—hematologic cancer	5.54e-06	6.87e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.52e-06	6.84e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.52e-06	6.84e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NUP214—hematologic cancer	5.48e-06	6.79e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.42e-06	6.72e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.37e-06	6.65e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—MTR—hematologic cancer	5.37e-06	6.65e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3R1—hematologic cancer	5.3e-06	6.57e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ENO2—hematologic cancer	5.26e-06	6.52e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.1e-06	6.33e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.03e-06	6.23e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—SDC1—hematologic cancer	4.99e-06	6.18e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CB—hematologic cancer	4.89e-06	6.06e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.77e-06	5.91e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.7e-06	5.83e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.5e-06	5.58e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CD44—hematologic cancer	4.24e-06	5.26e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NQO1—hematologic cancer	4.24e-06	5.26e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PTEN—hematologic cancer	4.23e-06	5.24e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.15e-06	5.15e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—EP300—hematologic cancer	4.03e-06	5e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CYCS—hematologic cancer	4.01e-06	4.98e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.99e-06	4.94e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.59e-06	4.45e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.54e-06	4.39e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.42e-06	4.24e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.35e-06	4.15e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.25e-06	4.03e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.25e-06	4.03e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CA—hematologic cancer	2.98e-06	3.7e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.87e-06	3.56e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.53e-06	3.14e-05	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—AKT1—hematologic cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.41e-06	2.99e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.24e-06	2.77e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.12e-06	2.63e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ALB—hematologic cancer	2.09e-06	2.6e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2e-06	2.48e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.85e-06	2.29e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PTEN—hematologic cancer	1.6e-06	1.98e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—EP300—hematologic cancer	1.52e-06	1.89e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—AKT1—hematologic cancer	9.21e-07	1.14e-05	CbGpPWpGaD
